and N,N'-dicyclohexylcarbodiimide (DCC, 4.63 g, 22 .4 mmol) were added into a 250 mL flask. The flask was evacuated and filled with N 2 . THF (80 mL) was added under N 2 and the reaction mixture was stirred under N 2 protection at room temperature for 24 h. The solid generated was filtered off and the THF solvent in the filtrate was evaporated under vacuum. The resulting residue was crystallized from petroleum ether to give the product as white solid (2.9 g, 49%). 1 
Per-2,3-di-O-methyl-6-O-(4-pyridinylethyl)carboxyl-#-cyclodextrin (T7*).
Per-2,3-di-O-methyl-"-cyclodextrin S3 ,S4 (87.7 mg, 0.066 mmol), 4-pyridinyl propanoic acid pentafluorophenol ester (670 mg, 2.11 mmol), 4-dimethylamino pyridine (162 mg, 1.32 mmol) were dried under vacuum for over 2 h, then pyridine (7.0 mL) was added. The mixture was stirred at 90°C for 5 h. MALDI-MS analysis indicated the completion of the reaction. The reaction mixture was cooled and the solvent was evaporated under vacuum. The residue was dissolved in chloroform (100 mL) and washed with water (100 mL # 2). The organic solution was evaporated to dryness. Column chromatography (chloroform/MeOH, 20/1, gradually increasing the polarity to 20/1.6, v/v) washed off the excess pentafluorophenol ester. The column was then eluted with solvent of increasing polarity (chloroform/MeOH, 1/1, v/v) to give the product, along with impurities which do not dissolve in pure chloroform. The product was finally extracted from the residue using chloroform and evaporation of the solvent gave the product T7* as light yellowish solid (137 mg, 92.1%). 1 79, 149.75, 149.33, 123.70 , 99.09, 81.54, 81.47, 80.38, 69.56, 63.22, 61.32, 58.83, 34.00, 29. Preparation of c-P6!T6* a) T6* (5.5 mg, 3.13 µmol) and P2 (20 mg, 12.5 µmol) were dissolved in chloroform (15 mL) and diisopropylamine (DIPA, 0.20 mL). The solution was sonicated for 2 h and cooled to room temperature. A catalyst solution was prepared by dissolving dichlorobis(triphenyl-phosphine)-palladium(II) (2.9 mg, 4.0 µmol), CuI (7.2 mg, 37 µmol) and 1,4-benzoquinone (5.4 mg, 50 µmol) in chloroform (15 mL) and DIPA (0.2 mL). The catalyst solution was added to the mixture and stirred under air at room temperature overnight. The reaction mixture was passed through a plug of alumina using chloroform as eluent. The crude mixture was separated on size exclusion column (Biobeads SX-1, 200-400 mesh) using toluene as eluent to give the product c-P6!T6* as reddish-brown solid (12 mg, 59%). b) T6* (5.5 mg, 3.13 µmol) and P1 (20 mg, 25 µmol) were dissolved in chloroform (15 mL) and diisopropylamine (DIPA, 0.20 mL). The solution was sonicated for 2 h and cooled to room temperature. A catalyst solution was prepared by dissolving dichlorobis(triphenyl-phosphine)-palladium(II) (2.9 mg, 4.0 µmol), CuI (7.2 mg, 37 µmol) and 1,4-benzoquinone (10.8 mg, 100 µmol) in chloroform (15 mL) and DIPA (0.2 mL). The catalyst solution was added to the mixture and the reaction was stirred under air at room temperature and UV-vis monitoring during the reaction process (0.5 h interval) indicated the reaction to completion at 6 h. The reaction mixture was passed through a plug of alumina using chloroform as eluent. The crude mixture was separated on size exclusion column (Biobeads SX-1, 200-400 mesh) using toluene as eluent. Two major bands were collected from the column: the first band was collected for the following c-P12!(T6*) 2 synthesis; the second band was collected, dried and precipitated using chloroform/methanol to give the product c-P6!T6* as reddish-brown solid (4.5 mg, 22% Preparation of c-P12!(T6*) 2 . The mixture collected in the procedure (b) in the c-P6!T6* synthesis was separated on size exclusion column (Biobeads SX-1, 200-400 mesh) using chloroform/pyridine (10/1, v/v) to remove the template. Recycling GPC (Shimadzu recycling GPC system equipped with LC-20 AD pump, SPD-20A UV detector and a set of JAIGEL 3H (20 x 600 mm) and JAIGEL 4H (20 x 600 mm) columns in toluene/1% pyridine as eluent, flow rate 3.5 mL/min) gave the template-free c-P12 intermediate (0.40 mg, 2.0%). c-P12 (0.40 mg, 0.042 µmol)and T6* (0.20 mg, 0.11 µmol) were dissolved in chloroform (2 mL) and plugged through a short basic alumina column. The solvent was evaporated and the residue was precipitated using chloroform/methanol to give the product c-P12!(T6*) 2 as black solid (0.39 mg, 70% from c-P12, 1.4% from P1). 1 H NMR: see Figure S15 ; MALDI- The 1 H-NMR spectrum of c-P12!(T6*) 2 is too complicated to be assigned in detail because this complex consists of a mixture of four diastereomers: the c-P12 can exist in two enantiomeric conformations, each of which can bind two T6* units with their narrow primary rings both pointing the same way or with their rims pointing in opposite directions. However the structure of c-P12!(T6*) 2 is supported by the fact that its 1 H NMR, 1 H DOSY spectra and UV-vis spectra are similar to those of the previously reported figure-of-eight complex c-P12!(T6) 2 . S6 
D. Circular Dichroism Spectroscopy
Circular dichroism spectra and the corresponding UV-Vis spectra were measured on a JASCO 815 instrument. 
E. Small-Angle X-ray Scattering Analysis of c-P6!T6* and c-P7!T7*
Synchrotron radiation SAXS data were collected using standard procedures on the I22 beamline at the Diamond Light Source (UK) equipped with a photon-counting detector. The beam was focused onto the detector placed at a distance of 1.25 m from the sample cell. The covered range of momentum transfer was 0.03 < q < 1.0 Å -1 (q = 4!sin(!)/", where 2! is the scattering angle and " = 1.00 Å is the X-ray wavelength). The data were normalized to the intensity of the transmitted beam; the scattering of the solvent was subtracted using an in-house program. To check for radiation damage during the SAXS experiment, the data were collected in 300 successive 1 s frames. Samples of c-P6!T6* and c-P7!T7* were dissolved in toluene at known concentrations (~10 -4 M) and placed in a solution cell with mica windows (1 mm path length). Simulated scattering curves from molecular models were obtained by fitting to the experimental scattering data using the program CRYSOL. S7 The program GNOM S8 was used to calculate pair distribution functions (PDF) and radii of gyration (R g ) from experimental and simulated scattering data. Titrations with porphyrin monomer P1' were carried out to compare the Lewis basicity of pyridine and ligands L1-L2. These results were not used in the calculation of effective molarities.
All titrations were performed in chloroform (passed through short basic alumina column to remove stabilizers) at 298 K. All titrations were carried out at constant porphyrin concentration by adding porphyrin to the ligand stock solution before titrations started. Titration curves were fitted to a 1:1 binding isotherm using the equation:
where A is the observed absorption at a specific wavelength or difference of absorption at two wavelengths; A initial is the starting absorption at this wavelength or difference of absorption in these two wavelengths; A # is the asymptotic final absorption at this wavelength or difference of absorption in these two wavelengths; K a is the association constant between ligand and porphyrin host; [L] is the concentration of ligand; [P] 0 is the concentration of porphyrin host.
The results are detailed in Table S1 and Figures S31-S38 . In the spectra, the bold black lines represent starting points and the red lines represent terminal points.
Table S1. The 1:1 association constants of P1' and ligands (1:1 association constants in M -1 ).
Ligand
Run 1 Run 2 Average Spectra pyridine (1.3±0.1) $ 10 4 (1.2±0.1) $ 10 4 (1.2±0.1) $ 10 4 Fig. S31 , S32 L1 (7.8±0.2) $ 10 3 (8.5±0.1) $ 10 3 (8.1±0.4) $ 10 3 Fig. S33, S34   L2 (2.8±0.1) $ 10 3 (2.5±0.1) $ 10 3 (2.6±0.2) $ 10 3 Fig. S35, S36   L3 (1.2±0.1) $ 10 4 (1.4±0.1) $ 10 4 (1.3±0.1) $ 10 4 
S33

F2. Titrations of Monodentate Ligands with Nanorings c-P6 and c-P7
c-P6 was titrated with the ligands shown in Fig. S39 (quinuclidine, pyridine, 4-phenylpyridine and methyl isonicotinate) to measure their association constants. Unless stated otherwise, all the titrations were performed in chloroform (passed through short basic alumina column) at 298 K and the concentrations of porphyrin nanorings were 1.8 µM. All titrations were carried out at constant porphyrin concentration by adding porphyrin to the ligand stock solution before titrations started.
Fig. S39
Ligands used for measurements of reference association constants of c-P6.
c-P7 was titrated with the ligands shown in Fig. S40 (quinuclidine, pyridine and 4-pyridinepropanoic acid methyl ester) to measure their association constants. The spectra for titration of c-P6 with monodentate ligands are slightly nonisobestic, which can lead to uncertainly in the association constant. This problem was minimized by taking the differences between absorption at 828 nm (the right shoulder of titration terminal spectra) and absorption at 736 nm (the left shoulder of titration starting spectra) to give the largest yet reliable change in absorption. The results were found to be self-consistent and consistent with previously published data. S9 Titration curves were fitted to a 1:1 binding isotherm using the equation (S.1) similar to Section F1. However, the [P] 0 is a 6-fold multiply for the concentration of c-P6 and 7-fold multiply for the concentration of c-P7, as they have multiple porphyrin units inside each molecule.
The results are listed in the tables and figures below. In the spectra, the bold black lines represent starting points and the red lines represent terminal points. Table S2 The association constants of c-P6 and ligands (1:1 association constants in M -1 ).
Ligand
Run 1 
Table S3
The association constants of c-P7 and ligands (1:1 association constants in M -1 ).
Ligand
S39
F3. Denaturation Titrations
c-P6!T6 was titrated with quinuclidine only, because quinuclidine is the only commonly used ligand to displace the template from c-P6!T6. The corresponding denaturation constant is labeled as K qp6t6 . c-P6!T6* and c-P7!T7* were titrated both with quinuclidine and pyridine. The corresponding denaturation constants are labeled as K qp6t6* , K pyp6t6* , K qp7t7* and K pyp7t7* , respectively. Unless stated otherwise, all the titrations were performed in chloroform (passed through short basic alumina column) at 298 K. All titrations were carried out at constant porphyrin concentration by adding porphyrin to the ligand stock solution before titrations started.
All the data were fitted to the n-dentate breaking-up binding isotherm, equation S.2.
where A is the observed absorption at a specific wavelength or difference of absorption in two wavelengths; A initial is the starting absorption at a specific wavelength or difference of absorption in two wavelengths; A # is the terminal absorption at a specific wavelength or difference of absorption in two wavelengths; K dn is the dissociation constant between ligand and porphyrin nanoring complex; [L] is the concentration of ligand;
[P] 0 is the concentration of porphyrin nanoring complex; n is the number of binding sites of nanoring complexes. For c-P6!T6 and c-P6!T6*, n = 6; for c-P7!T7*, n = 7.
The titration results are listed in the tables and figures below. In the spectra, the bold black lines represent starting points and the red lines represent terminal points. . S55, S56 quinuclidine, c-P6!T6* K qp6t6* (M -5 ) (7.6±0.6) $ 10 3 (8.3±0.7) $ 10 3 (8.0±0.7) $ 10 3 Fig. S57, S58 pyridine, c-P6!T6* K pyp6t6* (M -5 ) (3.9±0.4) $ 10 -6 (4.7±0.4) $ 10 -6 (4.3±0.4) $ 10 -6 Fig. S59, S60 quinuclidine, c-P7!T7* K qp7t7* (M -6 ) (1.6±0.1) $ 10 10 (2.3±0.2) $ 10 10 (2.0±0.3) $ 10 10 Fig. S61, S62 pyridine, 
F4. Calculation of Effective Molarities S9
The formation constants K f of nanoring-template complexes were calculated from equation S.3,
where K L is the association constants of the template-free ring c-Pn with ligand L; K dn,L is the denaturation constants of the nanoring-template complex with this ligand; n is the chelation number of nanoring-template complexes. For c-P6!T6 and c-P6!T6*, n = 6; for c-P7!T7*, n = 7. The uncertainty in LogK f was calculated from equation S.4:
The resulting values of log K f are listed in Table S5 : The geometric average effective molarities (!") of the nanoring complexes were calculated from equation S.5,
where K chem,n is the statistically corrected value of K f . As is shown in Fig. S65, for c-P6!T6 and c-P6!T6*, K ! = 768; for c-P7!T7*, K ! = 1792. K 1 is the reference single-site microscopic binding constant statistically corrected for binding to one face of a porphyrin (i.e. half of the binding constants measured in reference association titrations in Section F2). The uncertainties in the values of log!" were calculated from equation S.6:
The geometric average effective molarities of the nanoring complexes are listed in Table S6 : Table S6 The geometric average effective molarities of nanoring-template complexes.
Complex K 1 (M -1 ) K ! log!" (quinuclidine data) log!" (pyridine data) !" (M) c-P6!T6 (4.2±0.2) $ 10 3 768 2.25 ± 0.05 -180 ± 20 c-P6!T6* (6.5±0.5) $ 10 2 768 1.85± 0.06 1.89± 0.09 74 ± 20 c-P7!T7* (1.8±0.1) $ 10 4 1792 -0.16±0.14 -0.17±0.07 0.7 ± 0.1 Fig. S65 Statistical factors of c-P6!T6, c-P6!T6* and c-P7!T7*. 
